⚖️DEA Revokes Registration for Improper Controlled Substance Prescribing
The Drug Enforcement Administration (DEA) issued a revocation order for Margaret Dennis, D.M.D., for improper prescribing of controlled substances, citing numerous violations of federal and state laws. The findings include lack of medical justification, inadequate record-keeping, and failure to monitor potential abuse, highlighting significant compliance issues within the healthcare sector.
Learn More💊Importer of Controlled Substances Application by US Pharmacopeial Convention
United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice on Controlled Substances Application Correction
The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled substances.
Learn More💊Skalar Pharma LLC's Application for Importing Controlled Substances
Skalar Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Bulk Manufacturer Registration Application by Pisgah Laboratories
Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Siemens Healthcare Diagnostics Applies for Controlled Substances Registration
Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Revokes Registrations of Multiple Pennsylvania Pharmacies
The DEA issued an Order to Show Cause and Immediate Suspension of Registrations to several pharmacies, alleging violations related to the dispensing and recordkeeping of controlled substances. The findings indicate significant discrepancies in record management, endangering public health, and leading to potential revocation of their registration for the sale of drugs.
Learn More💊DEA Notice on Royal Emerald Pharmaceuticals' Import Application
Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️DEA Revocation Decision Impacting De Novo Services, LLC
The Drug Enforcement Administration (DEA) has issued an order revoking the registration of De Novo Services, LLC due to substantial violations in managing controlled substances and maintaining proper recordkeeping. The decision underscores the stringent compliance requirements enforced by federal regulations to protect public health and safety, highlighting the consequences of non-adherence.
Learn More⚖️DEA Decision on Svetlana Burtman
The Department of Justice's ruling on Svetlana Burtman highlights numerous violations of the Controlled Substances Act, including operating an unregistered practice and failing to maintain adequate records. This decision underscores the rigorous compliance requirements for healthcare providers regarding controlled substances. The ramifications may extend beyond individual practitioners, influencing broader regulatory practices in the healthcare industry.
Learn More